Track Fulgent Genetics's current cash ($23M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Fulgent Genetics (FLGT) currently reports a current cash of $23M as of March 2026. That compares with $67M in the prior-year period — down 65.2% year over year. Use the charts on this page to explore Fulgent Genetics's current cash history and peer comparisons.
Fulgent Genetics's current cash decreased from $67M to $23M — a 65.2% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Fulgent Genetics reported $23M in current cash as of March 2026. That compares with $67M in the prior-year period — down 65.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current current cash of $23M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Fulgent Genetics, and consider following FLGT for alerts when major investors trade the stock.
Fulgent Genetics is classified in the Healthcare sector. On current cash, it currently shows $23M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FLGT with unrelated industries.